Read the latest news about AMYPAD project, a European collaboration to improve the knowledge, diagnosis and treatment of Alzheimer's by using a Positron Emission Tomography (PET).
Thanks to this neuroimaging technique, widely used in the field of research, deposits of the Alzheimer’s disease associated amyloid-β protein in the brain can be detected and evaluated.
The research center of the Pasqual Maragall Foundation, the BBRC, participates in the project, together with seven other European centers.
The team of the research center of the Pasqual Maragall Foundation presents 6 oral communications and 15 posters, and participates in about fifteen international collaborations
A team of researchers from the AMYPAD consortium, led at BBRC, showed that the visual assessment used in clinical practice to evaluate amyloid PET images is sensitive to detecting the earliest stages of Alzheimer’s disease, and suggests a method to classify the extent of the pathology in the brain.
The meeting took place on October 10 and 11 in Barcelona
The group of scientists has presented in Los Angeles a total of 8 oral communications and 14 scientific posters
Dr José Luis Molinuevo will be the representative of AMYPAD at the Scientific Coordination Board of the new European project
Dr José Luis Molinuevo is participating in several sessions of the congress that is taking place in Lisbon, from the 26th to the 31st of March